Nicole Erler
@nerler.bsky.social
Biostatistician, Assistant Professor, Julius Center, UMC Utrecht
🔍 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗮𝗯𝗼𝘂𝘁 𝗵𝗮𝗻𝗱𝗹𝗶𝗻𝗴 #missingdata 𝗶𝗻 𝗹𝗼𝗻𝗴𝗶𝘁𝘂𝗱𝗶𝗻𝗮𝗹 𝘀𝘁𝘂𝗱𝗶𝗲𝘀?
Join Prof. Emmanuel Lesaffre and me on 𝟳 𝗡𝗼𝘃 𝟮𝟬𝟮𝟱 in 𝗣𝗿𝗮𝗴𝘂𝗲 for a one-day course on #𝗕𝗮𝘆𝗲𝘀𝗶𝗮𝗻 𝗠𝗲𝘁𝗵𝗼𝗱𝘀 𝗳𝗼𝗿 𝗠𝗶𝘀𝘀𝗶𝗻𝗴 𝗖𝗼𝘃𝗮𝗿𝗶𝗮𝘁𝗲𝘀 𝗶𝗻 𝗟𝗼𝗻𝗴𝗶𝘁𝘂𝗱𝗶𝗻𝗮𝗹 𝗦𝘁𝘂𝗱𝗶𝗲𝘀.
📅 Register until 31 Oct 2025
🔗 Details: sites.google.com/view/iscb-cz...
#RStats
Join Prof. Emmanuel Lesaffre and me on 𝟳 𝗡𝗼𝘃 𝟮𝟬𝟮𝟱 in 𝗣𝗿𝗮𝗴𝘂𝗲 for a one-day course on #𝗕𝗮𝘆𝗲𝘀𝗶𝗮𝗻 𝗠𝗲𝘁𝗵𝗼𝗱𝘀 𝗳𝗼𝗿 𝗠𝗶𝘀𝘀𝗶𝗻𝗴 𝗖𝗼𝘃𝗮𝗿𝗶𝗮𝘁𝗲𝘀 𝗶𝗻 𝗟𝗼𝗻𝗴𝗶𝘁𝘂𝗱𝗶𝗻𝗮𝗹 𝗦𝘁𝘂𝗱𝗶𝗲𝘀.
📅 Register until 31 Oct 2025
🔗 Details: sites.google.com/view/iscb-cz...
#RStats
ISCB ČR - 2025
ISCB Course on Bayesian Methods for Missing Covariates in Longitudinal Studies
Czech National Group of the International Society for Clinical Biostatistics,
in cooperation with the Institute of Compu...
sites.google.com
October 20, 2025 at 9:03 AM
🔍 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗮𝗯𝗼𝘂𝘁 𝗵𝗮𝗻𝗱𝗹𝗶𝗻𝗴 #missingdata 𝗶𝗻 𝗹𝗼𝗻𝗴𝗶𝘁𝘂𝗱𝗶𝗻𝗮𝗹 𝘀𝘁𝘂𝗱𝗶𝗲𝘀?
Join Prof. Emmanuel Lesaffre and me on 𝟳 𝗡𝗼𝘃 𝟮𝟬𝟮𝟱 in 𝗣𝗿𝗮𝗴𝘂𝗲 for a one-day course on #𝗕𝗮𝘆𝗲𝘀𝗶𝗮𝗻 𝗠𝗲𝘁𝗵𝗼𝗱𝘀 𝗳𝗼𝗿 𝗠𝗶𝘀𝘀𝗶𝗻𝗴 𝗖𝗼𝘃𝗮𝗿𝗶𝗮𝘁𝗲𝘀 𝗶𝗻 𝗟𝗼𝗻𝗴𝗶𝘁𝘂𝗱𝗶𝗻𝗮𝗹 𝗦𝘁𝘂𝗱𝗶𝗲𝘀.
📅 Register until 31 Oct 2025
🔗 Details: sites.google.com/view/iscb-cz...
#RStats
Join Prof. Emmanuel Lesaffre and me on 𝟳 𝗡𝗼𝘃 𝟮𝟬𝟮𝟱 in 𝗣𝗿𝗮𝗴𝘂𝗲 for a one-day course on #𝗕𝗮𝘆𝗲𝘀𝗶𝗮𝗻 𝗠𝗲𝘁𝗵𝗼𝗱𝘀 𝗳𝗼𝗿 𝗠𝗶𝘀𝘀𝗶𝗻𝗴 𝗖𝗼𝘃𝗮𝗿𝗶𝗮𝘁𝗲𝘀 𝗶𝗻 𝗟𝗼𝗻𝗴𝗶𝘁𝘂𝗱𝗶𝗻𝗮𝗹 𝗦𝘁𝘂𝗱𝗶𝗲𝘀.
📅 Register until 31 Oct 2025
🔗 Details: sites.google.com/view/iscb-cz...
#RStats
🌟 New Publication Alert! 🌟
Excited to share our new paper: 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝗦𝗰𝗵𝗲𝗱𝘂𝗹𝗲𝘀 𝗨𝘀𝗶𝗻𝗴 𝗮𝗻 𝗜𝗻𝘁𝗲𝗿𝘃𝗮𝗹-𝗖𝗲𝗻𝘀𝗼𝗿𝗲𝗱 𝗖𝗮𝘂𝘀𝗲-𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗝𝗼𝗶𝗻𝘁 𝗠𝗼𝗱𝗲𝗹.
🔗 doi.org/10.1002/sim....
with Zhenwei Yang, @drizopoulos.bsky.social , Eveline Heijnsdijk, Lisa Newcomb
Excited to share our new paper: 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝗦𝗰𝗵𝗲𝗱𝘂𝗹𝗲𝘀 𝗨𝘀𝗶𝗻𝗴 𝗮𝗻 𝗜𝗻𝘁𝗲𝗿𝘃𝗮𝗹-𝗖𝗲𝗻𝘀𝗼𝗿𝗲𝗱 𝗖𝗮𝘂𝘀𝗲-𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗝𝗼𝗶𝗻𝘁 𝗠𝗼𝗱𝗲𝗹.
🔗 doi.org/10.1002/sim....
with Zhenwei Yang, @drizopoulos.bsky.social , Eveline Heijnsdijk, Lisa Newcomb
Personalized Biopsy Schedules Using an Interval‐Censored Cause‐Specific Joint Model
Active surveillance (AS), where biopsies are conducted to detect cancer progression, has been acknowledged as an efficient way to reduce the overtreatment of prostate cancer. Most AS cohorts use fixe...
doi.org
May 28, 2025 at 6:36 AM
🌟 New Publication Alert! 🌟
Excited to share our new paper: 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝗦𝗰𝗵𝗲𝗱𝘂𝗹𝗲𝘀 𝗨𝘀𝗶𝗻𝗴 𝗮𝗻 𝗜𝗻𝘁𝗲𝗿𝘃𝗮𝗹-𝗖𝗲𝗻𝘀𝗼𝗿𝗲𝗱 𝗖𝗮𝘂𝘀𝗲-𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗝𝗼𝗶𝗻𝘁 𝗠𝗼𝗱𝗲𝗹.
🔗 doi.org/10.1002/sim....
with Zhenwei Yang, @drizopoulos.bsky.social , Eveline Heijnsdijk, Lisa Newcomb
Excited to share our new paper: 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 𝗦𝗰𝗵𝗲𝗱𝘂𝗹𝗲𝘀 𝗨𝘀𝗶𝗻𝗴 𝗮𝗻 𝗜𝗻𝘁𝗲𝗿𝘃𝗮𝗹-𝗖𝗲𝗻𝘀𝗼𝗿𝗲𝗱 𝗖𝗮𝘂𝘀𝗲-𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗝𝗼𝗶𝗻𝘁 𝗠𝗼𝗱𝗲𝗹.
🔗 doi.org/10.1002/sim....
with Zhenwei Yang, @drizopoulos.bsky.social , Eveline Heijnsdijk, Lisa Newcomb
Only 5 days left to apply for our 3 PhD positions at the @umcutrecht.bsky.social 🎓 🏃🏃♀️
HIRING!
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment.
More info: www.linkedin.com/feed/update/...
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment.
More info: www.linkedin.com/feed/update/...
HIRING!
We offer 3 fully funded PhD positions to work on research… | Maarten van Smeden
HIRING!
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment. Interested in one of these projects? Send us your motivational let...
www.linkedin.com
May 11, 2025 at 6:38 AM
Only 5 days left to apply for our 3 PhD positions at the @umcutrecht.bsky.social 🎓 🏃🏃♀️
Reposted by Nicole Erler
Still some spots available in our summer school on all things causal inference, 7-11 July in Utrecht! Discounts for those working in universities and non-profits, and affordable accommodation offered by @utrechtuniversity.bsky.social summer school!
April 28, 2025 at 8:01 AM
Still some spots available in our summer school on all things causal inference, 7-11 July in Utrecht! Discounts for those working in universities and non-profits, and affordable accommodation offered by @utrechtuniversity.bsky.social summer school!
Reposted by Nicole Erler
HIRING!
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment.
More info: www.linkedin.com/feed/update/...
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment.
More info: www.linkedin.com/feed/update/...
HIRING!
We offer 3 fully funded PhD positions to work on research… | Maarten van Smeden
HIRING!
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment. Interested in one of these projects? Send us your motivational let...
www.linkedin.com
April 25, 2025 at 6:31 AM
HIRING!
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment.
More info: www.linkedin.com/feed/update/...
We offer 3 fully funded PhD positions to work on research methodology with experts in a great medical research environment.
More info: www.linkedin.com/feed/update/...
Reposted by Nicole Erler
Just published a couple of pre-prints for those interested in sample size calculations for precise and fair individual-level predictions ... (not the end of the story, but a useful contribution we hope):
Binary outcomes: arxiv.org/abs/2407.09293
Survival outcomes: arxiv.org/abs/2501.14482
Binary outcomes: arxiv.org/abs/2407.09293
Survival outcomes: arxiv.org/abs/2501.14482
A decomposition of Fisher's information to inform sample size for developing fair and precise clinical prediction models -- part 1: binary outcomes
When developing a clinical prediction model, the sample size of the development dataset is a key consideration. Small sample sizes lead to greater concerns of overfitting, instability, poor performanc...
arxiv.org
February 12, 2025 at 4:15 PM
Just published a couple of pre-prints for those interested in sample size calculations for precise and fair individual-level predictions ... (not the end of the story, but a useful contribution we hope):
Binary outcomes: arxiv.org/abs/2407.09293
Survival outcomes: arxiv.org/abs/2501.14482
Binary outcomes: arxiv.org/abs/2407.09293
Survival outcomes: arxiv.org/abs/2501.14482